{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:34Z","timestamp":1787026474358,"version":"build-2736575974"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI049820"],"award-info":[{"award-number":["T32AI049820"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UH2AI122295"],"award-info":[{"award-number":["UH2AI122295"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00891","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T02:44:10Z","timestamp":1589251450000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques"],"prefix":"10.3389","volume":"11","author":[{"given":"Caylin G.","family":"Winchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibhuti B.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Yao","family":"Phuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Saqib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Maiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea M.","family":"Causgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassaundra L.","family":"Ameel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianne","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Jacob","family":"Borish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin C.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Dartois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philana Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Sassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnne L.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"B1","article-title":"Global Tuberculosis Report 2018","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1378\/chest.06-2949","article-title":"Pulmonary impairment after tuberculosis","volume":"131","author":"Pasipanodya","year":"2007","journal-title":"Chest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"a021196","DOI":"10.1101\/cshperspect.a021196","article-title":"Host-directed therapies for tuberculosis","volume":"5","author":"Tobin","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.micpath.2019.03.003","article-title":"Host-directed therapies to combat tuberculosis and associated non-communicable diseases","volume":"130","author":"Baindara","year":"2019","journal-title":"Microb Pathog."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.4049\/jimmunol.179.2.1178","article-title":"IL-1 receptor-mediated signal is an essential component of myd88-dependent innate response to mycobacterium tuberculosis infection","volume":"179","author":"Fremond","year":"2007","journal-title":"J Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.immuni.2015.11.016","article-title":"Interdependence between Interleukin-1 and tumor necrosis factor regulates tnf-dependent control of mycobacterium tuberculosis infection","volume":"43","author":"Di Paolo","year":"2015","journal-title":"Immunity."},{"key":"B7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1086\/315771","article-title":"Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis","volume":"182","author":"Juffermans","year":"2000","journal-title":"J Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","article-title":"Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection","volume":"35","author":"Mayer-Barber","year":"2011","journal-title":"Immunity."},{"key":"B9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ni.2474","article-title":"Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta","volume":"14","author":"Mishra","year":"2013","journal-title":"Nat Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"17072","DOI":"10.1038\/nmicrobiol.2017.72","article-title":"Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis","volume":"2","author":"Mishra","year":"2017","journal-title":"Nat Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1004426","DOI":"10.1371\/journal.ppat.1004426","article-title":"Allele-specific induction of IL-1beta expression by C\/EBPbeta and PU.1 contributes to increased tuberculosis susceptibility","volume":"10","author":"Zhang","year":"2014","journal-title":"PLoS Pathog."},{"key":"B12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1586\/17512433.1.4.479","article-title":"Clinical pharmacology of linezolid: an oxazolidinone antimicrobial agent","volume":"1","author":"Tan","year":"2008","journal-title":"Expert Rev Clin Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"265ra167","DOI":"10.1126\/scitranslmed.3009500","article-title":"PET\/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis","volume":"6","author":"Coleman","year":"2014","journal-title":"Sci Transl Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1056\/NEJMoa1201964","article-title":"Linezolid for treatment of chronic extensively drug-resistant tuberculosis","volume":"367","author":"Lee","year":"2012","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","article-title":"Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation","volume":"39","author":"Iyer","year":"2013","journal-title":"Immunity."},{"key":"B17","doi-asserted-by":"publisher","first-page":"cm1","DOI":"10.1126\/scisignal.3105cm1","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci Signal."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.clinthera.2004.12.019","article-title":"Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis","volume":"26","author":"Furst","year":"2004","journal-title":"Clin Ther."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3791\/56375","article-title":"Analysis of 18FDG PET\/CT imaging as a tool for studying Mycobacterium tuberculosis infection and treatment in non-human primates","author":"White","year":"2017","journal-title":"J Vis Exp."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e00505","DOI":"10.1128\/IAI.00505-17","article-title":"Rhesus macaques are more susceptible to progressive tuberculosis than cynomolgus macaques: a quantitative comparison","volume":"86","author":"Maiello","year":"2018","journal-title":"Infect Immun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1005739","DOI":"10.1371\/journal.ppat.1005739","article-title":"PET CT identifies reactivation risk in cynomolgus macaques with latent M. tuberculosis","volume":"12","author":"Lin","year":"2016","journal-title":"PLoS Pathog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nri.2017.69","article-title":"Heterogeneity in tuberculosis","volume":"17","author":"Cadena","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1128\/IAI.00064-06","article-title":"Early events in mycobacterium tuberculosis infection in cynomolgus macaques","volume":"74","author":"Lin","year":"2006","journal-title":"Infect Immun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ajpath.2012.05.009","article-title":"Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis","volume":"181","author":"Phuah","year":"2012","journal-title":"Am J Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1038\/s41564-019-0578-3","article-title":"Type I interferon-driven susceptibility to mycobacterium tuberculosis is mediated by IL-1Ra","volume":"4","author":"Ji","year":"2019","journal-title":"Nat Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1128\/AAC.00217-12","article-title":"Evaluation of a mouse model of necrotic granuloma formation using C3HeB\/FeJ mice for testing of drugs against Mycobacterium tuberculosis","volume":"56","author":"Driver","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.it.2017.01.004","article-title":"Regulation of inflammation- and infection-driven hematopoiesis","volume":"38","author":"Boettcher","year":"2017","journal-title":"Trends Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1128\/AAC.00277-13","article-title":"Radiologic responses in cynomolgus macaques for assessing tuberculosis chemotherapy regimens","volume":"57","author":"Lin","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1007337","DOI":"10.1371\/journal.ppat.1007337","article-title":"Lymph nodes are sites of prolonged bacterial persistence during mycobacterium tuberculosis infection in macaques","volume":"14","author":"Ganchua","year":"2018","journal-title":"PLoS Pathog."},{"key":"B30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0149-2918(01)80043-6","article-title":"Linezolid: an oxazolidinone antimicrobial agent","volume":"23","author":"Fung","year":"2001","journal-title":"Clin Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1004603","DOI":"10.1371\/journal.ppat.1004603","article-title":"Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization","volume":"11","author":"Gideon","year":"2015","journal-title":"PLoS Pathog."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13069-016-0043-3","article-title":"Active transforming growth factor-beta is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis","volume":"9","author":"DiFazio","year":"2016","journal-title":"Fibrogenesis Tissue Repair."},{"key":"B33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-016-0559-z","article-title":"The IL-1 cytokine family and its role in inflammation and fibrosis in the lung","volume":"38","author":"Borthwick","year":"2016","journal-title":"Semin Immunopathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","article-title":"Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo","volume":"184","author":"Mayer-Barber","year":"2010","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/mi.2011.13","article-title":"Role of innate cytokines in mycobacterial infection","volume":"4","author":"Cooper","year":"2011","journal-title":"Mucosal Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1084\/jem.192.3.347","article-title":"Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2","volume":"192","author":"Scanga","year":"2000","journal-title":"J Exp Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.1073\/pnas.0902745106","article-title":"IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation","volume":"106","author":"Ben-Sasson","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1084\/jem.20160393","article-title":"G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling","volume":"213","author":"Bajrami","year":"2016","journal-title":"J Exp Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtbi.2017.06.017","article-title":"Identifying mechanisms driving formation of granuloma-associated fibrosis during mycobacterium tuberculosis infection","volume":"429","author":"Warsinske","year":"2017","journal-title":"J Theor Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/mi.2011.14","article-title":"Macrophages and control of granulomatous inflammation in tuberculosis","volume":"4","author":"Flynn","year":"2011","journal-title":"Mucosal Immunol."},{"key":"B41","first-page":"101","article-title":"Negative regulators of in vivo erythropoiesis interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity","volume":"19","author":"Johnson","year":"1991","journal-title":"Exp Hematol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-019-02464-0","article-title":"Treatment for extreme drug-resistant tuberculosis wins US government approval","author":"Maxmen","year":"","journal-title":"Nature."},{"key":"B43","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.smim.2014.10.002","article-title":"Perspectives on host adaptation in response to mycobacterium tuberculosis: modulation of inflammation","volume":"26","author":"Dorhoi","year":"2014","journal-title":"Semin Immunol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1101\/792390","article-title":"Evaluation of IL-1 blockade as an adjunct to linezolid therapy for tuberculosis in mice and macaques","author":"Winchell","year":"2019","journal-title":"bioRxiv [Preprint]."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00891\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T02:44:15Z","timestamp":1589251455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00891\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2020.00891"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00891","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/792390","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"article-number":"891"}}